MALAT1 and melanoma: Furthermore, MALAT1 downregulates miR-34a expression level in melanoma cells and tumor specimens (Li et al., 2019), thereby it is a potential biomarker for many human cancer diagnosis as well as prognosis (Amodio et al., 2018; Li et al., 2018).